Close

JPMorgan Downgrades Alnylam Pharmaceuticals (ALNY) to Neutral

October 6, 2016 6:41 AM EDT Send to a Friend
JPMorgan downgraded Alnylam Pharmaceuticals (NASDAQ: ALNY) from Overweight to Neutral ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login